S. Verma

Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial

Nadia Harbeck, Shrividya Iyer, Nicholas C. Turner et al. · Annals of Oncology · 2016 · 178 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

James J. Rusthoven, Ian Quirt, N. Iscoe et al. · Journal of Clinical Oncology · 1996 · 167 citations

Medicine, Oncology, Pharmacology +9

Estimates of the lifetime costs of breast cancer treatment in Canada

B P Will, J.M. Berthelot, Christel Le Petit et al. · European Journal of Cancer · 2000 · 148 citations

Medicine, Oncology, Pharmacoeconomics +14

Surgical Margins and Handling of Soft-Tissue Sarcoma in Extremities: A Clinical Practice Guideline

Rita A. Kandel, N. Coakley, Joel Werier et al. · Current Oncology · 2013 · 113 citations · Full text

Medicine, Oncology, Surgery +17

Locoregional Therapy of Locally Advanced Breast Cancer: A Clinical Practice Guideline

Muriel Brackstone, Glenn G. Fletcher, Ian S. Dayes et al. · Current Oncology · 2015 · 41 citations · Full text

Medicine, Oncology, Surgery +17